Fri, May 29, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

New study examines hedge fund clone performance

Monday, August 20, 2012

Bailey McCann, Opalesque New York: Gregg S. Fisher, President & Chief Investment Officer of independent investment management firm Gerstein Fisher, and Nicolas P.B. Bollen, the E. Bronson Ingram Professor of Finance at the Owen Graduate School of Management, Vanderbilt University, have released a study, "Send in the Clones? Hedge Fund Replication Using Futures Contracts", that examines the performance of replication algorithms used to build hedge fund "clones". Replication products are becoming more popular with investors seeking lower fees, more transparency and greater liquidity than they can typically expect from a hedge fund.

In their study, Mr. Fisher and Dr. Bollen sought to replicate a series of Dow Jones Credit Suisse hedge fund indexes using five liquid futures contracts to permit low-cost, liquid exposure to most major asset classes. They then performed a series of rolling-window regressions, each of which yielded a set of allocation weights that were used to construct a clone portfolio.

According to data presented in the paper, clones show a high correlation to their underlying indices however, the Sharpe ratio performance of the clone is notably inferior to that of a hedge fund. "The only way clones can add value is by capturing the factor timing activity of the hedge funds they are attempting ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Hedge funds buy swathes of foreclosed subprimes, force up rents, float rent-bonds, Hedge funds buy Actavis, Valeant. ETFs join the party, The most loved biotechs of big hedge funds, Stocks to buy ... according to hedge funds, Atlantic City bond offering attracts hedge funds as buyers, Okumus Fund Management discloses huge new Ascent Capital Group stake[more]

    Hedge funds buy swathes of foreclosed subprimes, force up rents, float rent-bonds From Boingboing.com: When a giant hedge fund is bidding on all the foreclosed houses in a poor neighborhood, living humans don't stand a chance -- but that's OK, because rapacious investors make great landl

  2. Institutions - Institutional investors turn to real estate, planes, Assets at Bostonís five biggest family nonprofits rise to $3.5bn[more]

    Institutional investors turn to real estate, planes From Joins.com: The National Pension Service and domestic emerging market specialists who did not know where to invest in a low interest rate environment are turning to other investments like the blue-chip real estate market abroad.

  3. Regulatory - Hedge funds face tax as Iceland poised to end capital controls, Comment: Why alternatives need more transparency, not enforcement[more]

    Hedge funds face tax as Iceland poised to end capital controls From Bloomberg.com: Hedge funds and other investors who bought claims against Icelandís failed banks face a tax that targets the lendersí estates as the government prepares to unveil its plan for exiting capital controls in t

  4. Opalesque Exclusive: BMO launches multi-strat '40 act fund[more]

    Bailey McCann, Opalesque New York: As we reach new market highs, investors are looking for a way to diversify and protect their portfolios from a potential market correction. Liquid alternatives are rapidly gaining ground as a critical tool for investors to use to mitigate downside risk. The BMO

  5. All hedge fund strategies rebounded last week as market conditions normalize[more]

    Komfie Manalo, Opalesque Asia: After a difficult start this month, all hedge fund strategies ended last week in positive territory, as the Lyxor Hedge Fund Index gained 0.9% (-0.2% MTD, 3.3% YTD). According to Lyxor AMís latest Weekly Briefing, in t

 

banner